Swiss biotech startup hephaistos.bio hassecured €161,000 (CHF 150,000) from Venture Kick to accelerate the developmentof custom enzyme solutions for pharmaceutical and chemical manufacturing.Chemical ...
Amidst increasing demand for sustainable industrial processes and pharmaceutical innovation, funding for biotech solutions like directed enzyme evolution is critical for accelerating development and adoption.
This investment highlights the growing importance of biotechnology in transforming traditional chemical manufacturing, offering more sustainable and efficient production methods across various industries.
The accelerated development of custom enzyme solutions by hephaistos.bio will enable more eco-friendly and cost-effective production in pharmaceutical and chemical sectors, reducing reliance on conventional processes.
- · hephaistos.bio
- · Pharmaceutical manufacturers
- · Chemical manufacturers
- · Sustainable manufacturing initiatives
- · Traditional chemical synthesis methods
- · High-energy industrial processes
hephaistos.bio will accelerate the development and commercialization of its enzyme solutions, potentially securing further investment.
Broader adoption of enzyme-based manufacturing could lead to reduced environmental impact and lower production costs in target industries.
This could spur further innovation and investment in the synthetic biology sector, establishing new industry standards for sustainability.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Tech.eu